Key Highlights

  • Cycurion (NASDAQ:CYCU) traded at USD 2.36, up 7.27%, in pre-market trading on Tuesday, October 27, 2026; a USD 54.6 million, 10-year award signed in July 2026 contrasts with cash of USD 1,873,287 at June 30, 2026.
  • Cyabra (NASDAQ:CYAB) traded at USD 0.1420, up 7.09%; second quarter 2026 revenue of USD 1.9 million came with a net loss of about USD 3.4 million, and none of its October contract positions carried a disclosed value.
  • SCWorx (NASDAQ:WORX) traded at USD 2.18, up 6.34%; a customer agreement of Monday, October 19, 2026 carried undisclosed financial terms, and cash was about USD 1.3 million at Tuesday, June 30, 2026.
  • Datavault AI (NASDAQ:DVLT) traded at USD 0.0830, down 37.50%, from a close of USD 0.1328; none of the four moves followed an announcement dated on or just before the day. Pre-market quotes are thin.

Cycurion (NASDAQ:CYCU): a large award against a thin cash balance

Cycurion, Inc. (NASDAQ:CYCU), a cybersecurity and information technology services provider that also owns a public safety video business, gained according to the pre-market snapshot without a company-specific announcement dated on or just before Tuesday, October 27, 2026. The most recent releases are the notice of Thursday, October 22, 2026 of the third quarter earnings call and the announcement of Wednesday, October 21, 2026 of about USD 383,000 in new law enforcement contracts. The gain appears consistent with a rebound after recent declines and thin pre-market liquidity, an inference.

In its release of Friday, August 14, 2026, the company reported second quarter revenue of USD 3,757,076, a net loss of USD 4,039,567 against USD 5.3 million and a gross margin of 29.1% against 6.1% a year earlier. Net debt was USD 5.8 million. The award, for a state health and human services system, is expected to add more than USD 5 million in annual recurring revenue once work begins in November 2026. Dilution is the named risk, as the chief executive's letter of Tuesday, October 20, 2026 warned of potentially dilutive financings. A Nasdaq Discretionary Panel Monitor, a compliance watch, runs through Friday, October 1, 2027 after a 1-for-8 reverse split on Friday, August 28, 2026.

Cyabra (NASDAQ:CYAB): federal positions without disclosed values

Cyabra (NASDAQ:CYAB) sells artificial intelligence software that detects disinformation, impersonation and influence campaigns. No company-specific announcement dated Monday, October 26, 2026 or Tuesday, October 27, 2026 accompanied the move. The latest release, of Wednesday, October 21, 2026, named the company a Sample Vendor, meaning a representative provider, in 10 Gartner Hype Cycle reports. October also brought a multi-award contract position with the FBI, an enterprise agreement with a Fortune 500 media company and a National Security Advisory Council chaired by Michael R. Pompeo. The move appears consistent with continued interest after that news and thin liquidity, both inferences.

The company's release of Thursday, August 13, 2026 showed growth of 39% for the quarter ended Tuesday, June 30, 2026, with a gross margin of about 84% and an operating loss of about USD 3.1 million. The release also noted a USD 6.0 million private placement and gave no guidance. The FBI positions allow ordering through September 2031, but they do not guarantee orders. Market data show a market value of about USD 3.75 million, which implies repeated financing needs. The share price is far below the USD 1.00 level that Nasdaq listing rules use as a minimum bid benchmark, and no listing notice was identified in the releases reviewed.

SCWorx (NASDAQ:WORX): a customer win after a listing reprieve

SCWorx (NASDAQ:WORX), a provider of data management and normalisation services for healthcare supply chains, rose without a company-specific announcement dated on or just before the day. The most recent release, of Monday, October 19, 2026, announced an agreement with an independent, community-owned health system serving New Mexico, Arizona, Colorado and Utah. The Nasdaq Hearings Panel approved continued listing on Friday, October 2, 2026, and trading resumed on Wednesday, October 7, 2026 after a suspension of Tuesday, April 14, 2026. A Panel Monitor, a one-year compliance watch, runs through Saturday, October 2, 2027. The rise appears consistent with interest after the return to trading and with thin liquidity, both inferences.

The company's release of Wednesday, October 7, 2026 gave unaudited first half 2026 revenue of about USD 1.45 million, against about USD 1.40 million, while gross profit rose about 122% to USD 705,000 and the net loss narrowed to about USD 295,000 from USD 2.4 million. On Thursday, September 17, 2026 the company sold 350,000 units at USD 2.68 each for gross proceeds of about USD 938,000, with five-year warrants exercisable at USD 2.56. Proceeds are held in a segregated account until Monday, November 30, 2026. Publicly held shares were only 549,092, close to the 500,000 minimum, so warrant dilution and a renewed bid breach are the named risks.

Datavault AI (NASDAQ:DVLT): a revenue target against a collapsing quote

Datavault AI (NASDAQ:DVLT), a data sciences technology company that operates data management platforms and AI driven agents, fell without a company-specific announcement dated on or just before Tuesday, October 27, 2026, and it has announced no reverse split, equity offering or listing notice in the period reviewed. The latest items are the non-binding letter of intent of Thursday, October 22, 2026 to take a 19.9% equity stake in DataMEDS AI in exchange for an expanded technology licence. The fall appears consistent with thin liquidity in a quote below USD 0.10 and prior share price weakness, an inference.

The company's release of Wednesday, August 19, 2026 reported second quarter revenue up 287% from USD 1.7 million and gross profit of USD 2.9 million against USD 35,000 a year earlier. Operating costs rose faster: research and development was USD 7.2 million against USD 4.2 million, and general and administrative expense was USD 14.9 million against USD 6.5 million. The reiterated 2026 revenue target of at least USD 200 million is about 400% above the 2025 figure of USD 39.09 million. Market data show a net loss over the trailing twelve months of about USD 173.47 million and about 949.73 million shares outstanding, while class action notices are pending and the CyberCatch acquisition awaits completion.

Where Things Stand

The answer is that contract awards and cash split the four names because each award must be funded before it becomes revenue. Cycurion has a quantified award but little cash, Cyabra and SCWorx hold agreements whose values are undisclosed, and Datavault AI pairs a very large revenue target with heavy operating costs. Each move rests on thin liquidity and inference rather than a dated announcement.

The next catalysts are the Federal Reserve decision on Wednesday, October 28, 2026, the Cycurion third quarter call at 9:30 a.m. ET on Monday, November 16, 2026, the release of the SCWorx segregated proceeds on Monday, November 30, 2026 and the Datavault AI third quarter results, estimated for Monday, November 16, 2026. Pre-market prices are snapshots and can change before the open at 9:30 a.m. ET, and this is not investment advice.